… 3 days after receiving her first COVID-19 vaccine (Vaxzevria [… described in patients with
COVID-19, 1 polymerase chain … of people receiving COVID-19 vaccination, conclusions as to …

… To date, there is no specific antiviral treatment approved for COVID-19 and no vaccination
is currently available. Most hospitals are still relying on symptomatic treatment according to …

… be vaccinated against COVID-19 in an early stage before restrictions on adenoviral COVID-19
vaccinations … immune response to antigens and vaccines with higher antibody production …

… to the vaccine. Conclusions: Our study reports that mRNA-COVID-19 vaccination is safe also
in … The intended acceptance of the COVID-19 vaccine in frail patients confirms the positive …

… To identify studies reporting on immunological responses to COVID-19 vaccines in patients
with … (“cancer” or “malignancy”) AND (“Vaccine” OR “mRNA vaccine”) AND (“COVID-19” OR “…

… likely picture of uptake of a potential COVID-19 vaccine in the adult population. This …
COVID-19 vaccine among the Nigerian adult population and the predictors of uptake of the vaccine…

… COVID-19 vaccines have been proven to be safe in … COVID-19 vaccination-related
adverse events (AEs) in patients with SAIDs and healthy controls (HC) seven days post-vaccination …

… different COVID-19 vaccines in Pakistani healthcare professionals. The COVID-19 vaccine's
… The objective of this study was to see if various COVID-19 vaccinations had any negative …

… The heightened cytokine storm in COVID-19 patients leads to an … The COVID-19 patients
suffered severe lung deficiency often … Meanwhile, few new vaccines were developed to guard …

… COVID-19 mRNA vaccine, and a cohort of patients with influenza. We also compared the
COVID-19 … for the risk following the ChAdOx1 nCoV-19 vaccine, using the European Medicines …